3337 Safety and effectiveness analysis of V600 BRAF-mutated metastatic melanoma (MM) patients (pts) from the dabrafenib (D) plus trametinib (T) named patient programme (NPP) - DESCRIBE II study
作者
Victoria G. Atkinson,Johannes V. van Thienen,Grant A. McArthur,Geke A.P. Hospers,Georgina Venetia Long,Fabrizio Carnevale‐Schianca,Skaistė Tulytė,D. Stein,Michael E Bassel,Klaus Freivogel,Lindi D Dalland,Mike R Lau,Philippe Legenne,Pier Francesco Ferrucci